🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this first-in-human study is to evaluate the safety, tolerab...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-07-31
Trial ID
NCT07094113
Treatments Being Tested
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
The ADAPT Study is a longitudinal observational cohort study examining wome...
Status
Active Not Recruiting
Location
University of California, San Francisco
Start Date
2019-03-16
Trial ID
NCT03888404
This trial is conducted in the United States of America (USA). The aim of t...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2011-10
Trial ID
NCT01473953
Treatments Being Tested
A Phase 1, first in human (FIH), single-centre, double-blind, randomized, p...
Status
Terminated
Location
HMR
Start Date
2022-04-14
Trial ID
NCT05323110
Part 1 will be a dose escalation study of IV ICT01 (a monoclonal antibody t...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2020-03-05
Trial ID
NCT04243499
Treatments Being Tested
The study design will be a cohort study to determine the incidence of FI sy...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-07
Trial ID
NCT01166399
This study will assess the safety, tolerability, immunogenicity, and pharma...
Status
Completed
Location
Research Site
Start Date
2022-07-12
Trial ID
NCT05452304
Study consists of two main parts to explore tacabrutideg recommended dosing...
Status
Recruiting
Location
University of Alabama At Birmingham Hospital
Start Date
2021-09-13
Trial ID
NCT05006716
Treatments Being Tested
This will be a phase I, randomized, double-blind, placebo-controlled, singl...
Status
Completed
Location
Ascletis
Start Date
2024-07-13
Trial ID
NCT06427590
Treatments Being Tested